Pediatric Pain Assessment: Choosing the Right Scale for Every Age Group

Accurate pain assessment in children is challenging because young children cannot reliably verbalize their pain experience. However, validated tools exist for every age group, and consistent use of appropriate scales improves pain management outcomes. Self-report remains the gold standard for children capable of effective communication, while behavioral observation scales are essential for preverbal children and those with cognitive impairment.

The Society of Critical Care Medicine (SCCM) 2022 guidelines provide evidence-based recommendations for pain assessment in critically ill pediatric patients:

Self-Report Scales (≥6 years): The SCCM suggests that in critically ill pediatric patients 6 years old and older who are capable of communicating, pain assessment via self-report should be routinely performed using the Visual Analog Scale (VAS), Numeric Rating Scale, Oucher Scale, or Wong-Baker FACES pain scale (conditional recommendation, low-level evidence).

Behavioral/Observational Scales: The SCCM recommends the use of either the FLACC or COMFORT-B scales for assessing pain in noncommunicative critically ill pediatric patients (strong recommendation, moderate-level evidence). The SCCM recommends the use of observational pain assessment tools rather than vital signs alone for assessment of postoperative pain in critically ill pediatric patients (strong recommendation, moderate-level evidence).

Sedation Assessment: The SCCM recommends the use of the COMFORT-B Scale or State Behavioral Scale (SBS) to assess level of sedation in mechanically ventilated pediatric patients (strong recommendation, moderate-level evidence). The SCCM suggests the use of the Richmond Agitation-Sedation Scale (RASS) to assess level of sedation in mechanically ventilated pediatric patients (conditional recommendation, low-level evidence).

Iatrogenic Withdrawal Syndrome: The SCCM recommends use of either the Withdrawal Assessment Tool-1 (WAT-1) or Sophia Observation Scale (SOS) for the assessment of iatrogenic withdrawal syndrome due to opioid or benzodiazepine withdrawal in critically ill pediatric patients (strong recommendation, moderate-level evidence). The SCCM suggests routine withdrawal screening after a shorter duration (3–5 days) when higher opioid or benzodiazepine doses are used (conditional recommendation, moderate-level evidence).

Matching the Scale to the Age

The following figure from a 2019 JAMA Pediatrics systematic review illustrates validated pain and sedation scales organized by age group (preterm infants, term infants, and toddlers) and clinical context (acute pain, prolonged pain, postoperative pain, and sedation). Only scales meeting criteria for construct validity, internal consistency, interrater reliability, and defined cutoff points are included:

!Figure 3 Overview of Relevant Scales With Cutoff

Neonates: PIPP-R, N-PASS, and CRIES

The American Academy of Pediatrics recommends five scales for neonatal pain assessment: NFCS, PIPP, N-PASS, BIIP, and APN/DAN. Among these:

PIPP/PIPP-R (Premature Infant Pain Profile-Revised): Validated for procedural pain in preterm and term neonates. Includes gestational age, behavioral state, heart rate, oxygen saturation, and facial actions (brow bulge, eye squeeze, nasolabial furrow). The PIPP has shown good psychometric properties for content, concurrent, and construct validity as well as interrater reliability.

N-PASS (Neonatal Pain, Agitation and Sedation Scale): Developed for prolonged pain, sedation, and acute procedural pain in infants 23–40 weeks gestational age. Includes 5 criteria (crying-irritability, behavioral state, facial expression, extremity tone, vital signs) scored 0–2 for pain/agitation and 0 to −2 for sedation.

CRIES (Crying, Requires oxygen, Increased vital signs, Expression, Sleeplessness): A 10-point scale validated for postoperative neonatal pain. Each of the five domains is scored 0–2. CRIES correlates well with PIPP for the first 72 hours after surgery in both term and preterm infants.

A 2025 Cochrane systematic review identified 65 neonatal pain rating scales, with PIPP/PIPP-R, N-PASS, and COMFORT-neo among the most extensively validated.

Infants and Preverbal Children: FLACC

The FLACC scale (Face, Legs, Activity, Cry, Consolability) is one of the most widely used behavioral observation pain scales for children who cannot self-report. Key evidence:

• Age range: Validated for approximately 2 months to 7 years of age
• Scoring: Five domains, each scored 0–2, yielding a total score of 0–10
• Postoperative pain: Strong evidence supports FLACC for postoperative pain assessment in critically ill children
• Procedural pain: A 2018 study demonstrated high interrater reliability (0.92) and intrarater reliability (0.87), with sensitivity of 94.9% and specificity of 73.5% at a cutoff of 2
• Emergency department: A 2017 study confirmed high interrater reliability in children 6 months to 5 years with acute pain
• Cognitive impairment: The revised FLACC was developed and validated for use in nonverbal and cognitively impaired children

A 2023 systematic review concluded that FLACC can be considered for measuring observational pain in infants and children, though further studies are needed to provide more robust evidence.

Self-Report Scales: Ages 4–6 Years

Self-report is the gold standard for pain assessment in children capable of effective communication. However, a 2019 systematic review found that no self-report measures could be recommended for children younger than 6 years, identifying a need for further measurement refinement in this age range.

For children 4–7 years old, several options exist:

Faces Pain Scale-Revised (FPS-R): Validated for children as young as 4–5 years. A 6-face scale scored 0–10 with strong correlation (r=0.93) with visual analogue scales. The FPS-R has high cross-cultural validity, construct validity, and responsiveness.

Wong-Baker FACES Pain Rating Scale: Six faces from smiling to crying, scored 0–10. Children prefer this scale when given a choice, but the smiling and crying anchor faces may confound pain intensity with affect.

Simplified scales for 4-year-olds: A 2017 study validated simplified 2-step scales (yes/no for pain presence, then mild/moderate/severe) that improved discrimination of pain from no pain in 4-year-olds compared with standard FPS-R.

Pain Block scale: A concrete ordinal scale validated for 4–7 year-olds who have difficulty understanding faces scales, with correlation coefficient of 0.82 with FPS-R.

Self-Report Scales: Ages 6 Years and Older

For children ≥6 years old, the following scales are strongly recommended for acute pain:

• Numeric Rating Scale (NRS-11): 0–10 scale; most widely used
• Faces Pain Scale-Revised (FPS-R): 6 faces scored 0–10
• Color Analogue Scale (CAS): Graduated color intensity
• Visual Analogue Scale (VAS): 100mm line; children ≥8 years can generally comply

Only weak recommendations could be made for self-report measures for postoperative and chronic pain due to limited evidence.

Sedated and Ventilated Children: COMFORT-B

The COMFORT-B scale is validated for both pain and sedation assessment in critically ill pediatric patients:

• Domains: Alertness, calmness, respiratory response, crying, physical movement, muscle tone, and facial tension (behavioral items only; vital signs removed from original COMFORT scale)
• Scoring: Each domain rated 1–5, total score 6–30
• Cutoff points: ≤10 indicates oversedation; ≥23 indicates undersedation
• Sedation depth: Light (17–22), moderate (11–16), or deep (6–10)

The COMFORT-B scale removed vital sign elements from the original COMFORT scale due to concerns regarding their reliability for assessment of pain and distress during critical illness.

Iatrogenic Withdrawal Syndrome: WAT-1

The Withdrawal Assessment Tool-1 (WAT-1) is validated for monitoring iatrogenic withdrawal syndrome in pediatric ICU patients:

• Structure: 11-item (12-point) scale assessing motor-related symptoms and behavioral state
• Scoring: Scores ≥3 are consistent with the presence of withdrawal
• Validation: Validated in 126 children (median age 1.6 years) from 21 centers exposed to ≥5 days of opioids
• Psychometric properties: High-quality evidence for reliability, structural validity, criterion validity, and feasibility
• Limitation: Cannot differentiate between opioid and benzodiazepine withdrawal

The AAP 2025 clinical report recommends that providers familiarize themselves with the WAT-1 or SOS scales to detect early signs of withdrawal so treatment strategies can be implemented.

Pain Assessment by Age Group

Practical Implementation

Protocol Development

• Specify which scale applies to each age group and clinical situation
• Define action thresholds (e.g., FLACC ≥4 triggers reassessment and intervention consideration)
• Train all staff on consistent scoring criteria
• Reassess after interventions to evaluate effectiveness

Key Principles

1. Self-report is the gold standard for children ≥6 years who can communicate effectively
2. Behavioral scales are essential for preverbal children and those unable to self-report
3. Vital signs alone are insufficient — use validated observational tools
4. Consistency matters — use the same scale across assessments for trending
5. Age-appropriate interpretation — a frightened or fatigued young child may not follow commands, which does not indicate brain injury or pain

Special Populations

• Cognitive impairment: Use revised FLACC with individualized behavioral descriptors
• Neuromuscular blockade: No pain or sedation tools have been validated for patients receiving NMBAs; vital sign changes may indicate acute pain and should be addressed
• Palliative care: FPS-R recommended for self-assessment; FLACC/revised FLACC and Paediatric Pain Profile (PPP) recommended for observational assessment

Key Clinical Priorities

1. Match the scale to the patient: Age, developmental level, and clinical context determine appropriate tool selection.
2. Self-report is gold standard for ≥6 years: NRS-11, FPS-R, and CAS are strongly recommended for acute pain.
3. FLACC for preverbal children: Validated for ages 2 months to 7 years; revised FLACC for cognitive impairment.
4. COMFORT-B for sedated patients: Assesses both pain and sedation depth; cutoffs guide intervention.
5. WAT-1 for withdrawal: Score ≥3 indicates withdrawal; begin screening after 3–5 days of opioid/benzodiazepine exposure.
6. Avoid vital signs alone: Physiological measures reflect stress reactions not correlated with self-reported pain.
7. No validated self-report for <6 years: Simplified scales may help 4–5 year-olds; behavioral observation remains primary for younger children.
8. Reassess after intervention: Pain scores should decrease after analgesia; persistent elevation warrants reassessment.
9. Document consistently: Use the same scale across assessments to enable trending.
10. Train the team: Interrater reliability depends on standardized training and consistent application.

Accurate pain assessment using age-appropriate, validated tools is the foundation of effective pediatric pain management. Consistent application of these scales across clinical settings improves recognition of pain and enables timely, appropriate intervention.

References

1. Birnie KA, Hundert AS, Lalloo C, Nguyen C, Stinson JN. Recommendations for Selection of Self-Report Pain Intensity Measures in Children and Adolescents: A Systematic Review and Quality Assessment of Measurement Properties. Pain. 2019;160(1):5-18.
2. Krauss BS, Calligaris L, Green SM, Barbi E. Current Concepts in Management of Pain in Children in the Emergency Department. Lancet. 2016;387(10013):83-92.
3. Smith HAB, Besunder JB, Betters KA, et al. 2022 Society of Critical Care Medicine Clinical Practice Guidelines on Prevention and Management of Pain, Agitation, Neuromuscular Blockade, and Delirium in Critically Ill Pediatric Patients With Consideration of the ICU Environment and Early Mobility. Pediatr Crit Care Med. 2022;23(2):e74-e110.
4. Giordano V, Edobor J, Deindl P, et al. Pain and Sedation Scales for Neonatal and Pediatric Patients in a Preverbal Stage of Development: A Systematic Review. JAMA Pediatr. 2019;173(12):1186-1197.
5. Färnqvist K, Olsson E, Garratt A, et al. Clinical Rating Scales for Assessing Pain in Newborn Infants. Cochrane Database Syst Rev. 2025;4:MR000064.
6. Krechel SW, Bildner J. CRIES: A New Neonatal Postoperative Pain Measurement Score. Initial Testing of Validity and Reliability. Paediatr Anaesth. 1995;5(1):53-61.
7. McNair C, Ballantyne M, Dionne K, Stephens D, Stevens B. Postoperative Pain Assessment in the Neonatal Intensive Care Unit. Arch Dis Child Fetal Neonatal Ed. 2004;89(6):F537-41.
8. Chan AY, Ge M, Harrop E, et al. Pain Assessment Tools in Paediatric Palliative Care: A Systematic Review of Psychometric Properties and Recommendations for Clinical Practice. Palliat Med. 2022;36(1):30-43.
9. Crellin DJ, Harrison D, Santamaria N, Babl FE. Systematic Review of the Face, Legs, Activity, Cry and Consolability Scale for Assessing Pain in Infants and Children: Is It Reliable, Valid, and Feasible for Use? Pain. 2015;156(11):2132-2151.
10. Best Practices Guidelines For Acute Pain Management In Trauma Patients. Bernard A, Oyler DR, Anglen JO, et al. American College of Surgeons (2020).
11. Crellin DJ, Harrison D, Santamaria N, Huque H, Babl FE. The Psychometric Properties of the FLACC Scale Used to Assess Procedural Pain. J Pain. 2018;19(8):862-872.
12. Kochman A, Howell J, Sheridan M, et al. Reliability of the Faces, Legs, Activity, Cry, and Consolability Scale in Assessing Acute Pain in the Pediatric Emergency Department. Pediatr Emerg Care. 2017;33(1):14-17.
13. Peng T, Qu S, Du Z, et al. A Systematic Review of the Measurement Properties of Face, Legs, Activity, Cry and Consolability Scale for Pediatric Pain Assessment. J Pain Res. 2023;16:1185-1196.
14. Tomlinson D, von Baeyer CL, Stinson JN, Sung L. A Systematic Review of Faces Scales for the Self-Report of Pain Intensity in Children. Pediatrics. 2010;126(5):e1168-98.
15. Hicks CL, von Baeyer CL, Spafford PA, van Korlaar I, Goodenough B. The Faces Pain Scale-Revised: Toward a Common Metric in Pediatric Pain Measurement. Pain. 2001;93(2):173-183.
16. Emmott AS, West N, Zhou G, et al. Validity of Simplified Versus Standard Self-Report Measures of Pain Intensity in Preschool-Aged Children Undergoing Venipuncture. J Pain. 2017;18(5):564-573.
17. Jung JH, Lee JH, Kim DK, et al. Validation of the "Pain Block" Concrete Ordinal Scale for Children Aged 4 to 7 Years. Pain. 2018;159(4):656-662.
18. Ista E, van Dijk M, Tibboel D, de Hoog M. Assessment of Sedation Levels in Pediatric Intensive Care Patients Can Be Improved by Using the COMFORT "Behavior" Scale. Pediatr Crit Care Med. 2005;6(1):58-63.
19. Miatello J, Palacios-Cuesta A, Radell P, et al. Inhaled Isoflurane for Sedation of Mechanically Ventilated Children in Intensive Care (IsoCOMFORT): A Multicentre, Randomised, Active-Control, Assessor-Masked, Non-Inferiority Phase 3 Trial. Lancet Respir Med. 2025;13(10):897-910.
20. Franck LS, Scoppettuolo LA, Wypij D, Curley MAQ. Validity and Generalizability of the Withdrawal Assessment Tool-1 (WAT-1) for Monitoring Iatrogenic Withdrawal Syndrome in Pediatric Patients. Pain. 2012;153(1):142-148.
21. Zaccagnini M, Ataman R, Nonoyama ML. The Withdrawal Assessment Tool to Identify Iatrogenic Withdrawal Symptoms in Critically Ill Paediatric Patients: A COSMIN Systematic Review of Measurement Properties. J Eval Clin Pract. 2021;27(4):976-988.
22. Adler AC, Siegel LB, Wilder RT, Good J. Recognition and Management of Iatrogenically Induced Opioid Dependence and Withdrawal in Children: Clinical Report. Pediatrics. 2025;e2025073169.